Latest from @CombatCancer on Twitter

🇵🇱First successful Combat PRS+A-HIPEC Cases after CRS done at the Lower Silesian Oncology Institute in Wroclaw last week🇵🇱 with our local partner Meden-Inmed Sp. z o.o.!
Many thanks to Prof.Dr.Bebenek and his team for the opportunity.@CombatCancer @ESSOnews @operarelcancer #HIPEC

Great results from our friends @DukeUrology on the use of HIVEC in the USA.

“HIVEC is a safe and well-tolerated substitute for BCG during global shortages”

👏🏻👏🏻👏🏻 @DominicGrimberg @BrantInman

#BladderCancer #Cancer #HIVEC



https://www.sciencedirect.com/science/article/abs/pii/S1078143920306542

Intravesical hyperthermia with high-dose mitomycin-C shows promise as BCG alternative for NMIBC

"Our study demonstrates the feasibility of HIVEC MMC and suggests it is a reasonable substitute for BCG during global shortages," says urologist Scott...

www.urologytimes.com

Here I go again, this treatment is amazing and I’m so grateful to ⁦@NorthBristolNHS⁩ #urology for providing this ‘maintenance’ #bladdercancer ⁦@CombatCancer⁩ ⁦@Actionbladderca⁩

@alarjosan @HUReinaSofia @IMIBIC @GECOP_ @operarelcancer @SPeritoneum @aecirujanos @ESSOnews @Hospital_FJD Congrats @alarjosan and team!
Proud to be working with you!
👏🏻👏🏻👏🏻👏🏻👏🏻

Yet another publication showing #HIVEC to be a viable, safe and well tolerated treatment for BCG failure patients with both #mitomycin and #epirubicin.
Thanks to @francescok86 for his great work.
#BladderCancer #Hyperthermia #BCG
https://www.urotoday.com/recent-abstracts/urologic-oncology/bladder-cancer/125687-outcomes-and-complications-of-hyperthermic-intravesical-chemotherapy-using-mitomycin-c-or-epirubicin-for-patients-with-non-muscle-invasive-bladder-cancer-after-bacillus-calmette-guerin-treatment-failure.html

Yet another publication showing #HIVEC to be a viable, safe and well tolerated treatment for BCG failure patients with both #mitomycin and #epirubicin.
Thanks to @francescok86 for his great work.
#BladderCancer #Hyperthermia #BCG
https://www.urotoday.com/recent-abstracts/urologic-oncology/bladder-cancer/125687-outcomes-and-complications-of-hyperthermic-intravesical-chemotherapy-using-mitomycin-c-or-epirubicin-for-patients-with-non-muscle-invasive-bladder-cancer-after-bacillus-calmette-guerin-treatment-failure.html

📢NEXT WEEK📢Prophylactic #peritoneal Management of High-Risk #ColonCancer

🗓️3 NOV-18.30 CEST

🗣Dr @AndreasBrandl8, Dr @alarjosan, Dr Diane Goéré & Dr Pieter Tanis ➡️https://lnkd.in/gNsACYN

#HIPEC #PeritonealMetastases #colorectalsurgery #colorectalcancer @CombatCancer

Load More...